{"document_type": "article", "byline": {"contributor": "", "person": [{"role": "reported", "firstname": "Andrew", "organization": "", "rank": 1, "lastname": "POLLACK"}, {"role": "reported", "firstname": "Emmarie", "organization": "", "rank": 2, "lastname": "HUETTEMAN"}], "original": "By ANDREW POLLACK and EMMARIE HUETTEMAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": "Former Turing Pharmaceuticals chief executive Martin Shkreli refuses to answer questions during House Committee on Oversight and Government Reform hearing, exercising Fifth Amendment; Shkreli, who faces federal securities fraud charges, endures harsh criticism from lawmakers related to rising drug prices.  ", "multimedia": [], "headline": {"print_headline": "Hearing on Drug Pricing Delivers Spectacle but Few Answers", "main": "Martin Shkreli Invokes the Fifth Amendment During Grilling by Congress"}, "print_page": "1", "keywords": [{"value": "Shkreli, Martin (1983- )", "is_major": "Y", "rank": "1", "name": "persons"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Turing Pharmaceuticals AG", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Generic Brands and Products", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "House Committee on Oversight and Government Reform", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Schiller, Howard B", "is_major": "N", "rank": "8", "name": "persons"}], "snippet": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "source": "The New York Times", "lead_paragraph": "Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.", "word_count": "1292", "pub_date": "2016-02-05T00:00:00Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/02/05/business/drug-prices-valeant-martin-shkreli-congress.html", "_id": "56b325bd38f0d82036f0aa60"}